筛选新的药物靶点可以通过抑制HBV复制必需的一个基因或者保持HBV所引起的AT R损伤途径中的一种失调反应。
We have designed a strategy to select new drug targets that inhibit a cellular gene required for HBV replication or restore a response stalled by HBV in the ATR DNA damage pathway.
他说该机构必须对新技术明确立场，例如基因复制或者克隆。
He says that the agency must take a position on new technologies, such as genetic copying or cloning.
应用推荐